General Information of the Compound
Compound ID |
CP0039345
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1,2-benzoxazol-3-ylmethanesulfonamide
Show/Hide
|
||||||||||||||||||
Synonyms |
1,2-Benzisoxazole-3-methanesulfonamide
1,2-benzoxazol-3-ylmethanesulfonamide
1-(1,2-Benzoxazol-3-Yl)methanesulfonamide
1-(1,2-benzisoxazol-3-yl)methanesulfonamide
3-(Sulfamoylmethyl)-1,2-benzisoxazole
3-sulfamoylmethyl-1,2-benzisoxazole
AD 810
AD-810
AD-810N
E-2090
Elan brand of zonisamide
Exceglan
Excegram
Excegran
Excegran (TN)
PD 110843
PD-110843
SPR_2
Tremode
Trerief
Zonegran
Zonegran (TN)
Zonegran, Zonisamide
Zonisamida
Zonisamida [Spanish]
Zonisamide
Zonisamide (JAN/USAN/INN)
Zonisamide (ZNS)
Zonisamide [USAN:BAN:INN:JAN]
Zonisamide monosodium
Zonisamidum
Zonisamidum [Latin]
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C8H8N2O3S
|
||||||||||||||||||
Molecular Weight |
212.23
|
||||||||||||||||||
Canonical SMILES |
NS(=O)(=O)Cc1noc2ccccc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)
Show/Hide
|
||||||||||||||||||
InChIKey |
UBQNRHZMVUUOMG-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
68291-97-4
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound